The IL‐10 level in the SF@CP@Gel treatment group was 5.01 times greater than that in the dry eye model without drug treatment group (p < 0.001), and there were significant differences between the SF@CP treatment group and the SF@CP@Gel treatment group (p < 0.05). The gene discussed is IL10; the disease is dry eye syndrome.